Amy Pott

Amy Pott has filed trades across 2 companies (mainly through SEDI), most often in Eupraxia Pharmaceuticals Inc. and enGene Therapeutics Inc. The record holds 6 filings, for trades running from 16 June 2026 to 25 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 30 June 2026, reports a transaction in Eupraxia Pharmaceuticals Inc. Typically, a trade is published a median of 9 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.